心脏磁共振与常规危险因素在非阻塞性冠状动脉心肌梗死中的预后作用
本研究回顾性纳入388例非阻塞性冠状动脉心肌梗死(MINOCA)患者,行1.5-T心脏磁共振(CMR)检查并前瞻性随访全因死亡。CMR在中位37天时明确74%患者的病因(心肌炎25%、心肌梗死25%、心肌病25%、正常26%)。中位随访1262天(3.5年)期间死亡率5.7%,心肌病组预后最差(死亡率15%),心肌梗死组4%,心肌炎和正常CMR组均为2%。多变量Cox回归显示,CMR诊断心肌病和就诊心电图ST段抬高是仅有的两个显著死亡预测因素。
要点
- CMR在中位37天时可明确74% MINOCA患者的病因,其中心肌炎、心肌梗死、心肌病各占25%,正常占26%。
- 心肌病组死亡率15%最高,心肌梗死组4%,心肌炎和正常CMR组均为2%。
- CMR诊断心肌病和就诊心电图ST段抬高是仅有的两个显著死亡预测因素,具备0、1、2个因素者死亡率分别为2%、11%、21%。
核心结论
- 在较大样本的MINOCA患者队列中,CMR(中位37天)可为74%患者明确最终诊断;心肌病死亡率最高,其次为心肌梗死;最强的死亡预测因素为CMR诊断心肌病和就诊心电图ST段抬高。
研究设计与样本
- 回顾性队列研究,从注册数据库连续纳入388例MINOCA患者,行1.5-T CMR综合方案(电影、T2加权和延迟钆增强序列),并前瞻性随访全因死亡。
关键影像表现/征象
- CMR表现分为四类:心肌梗死(栓塞/自发再通)、心肌炎、心肌病和正常CMR。
- CMR在中位37天时识别了74%患者的肌钙蛋白升高原因(心肌炎25%、心肌梗死25%、心肌病25%),正常CMR占26%。
诊断标准与关键数值
- 中位随访1262天(3.5年)期间,全因死亡率为5.7%。
- 心肌病组死亡率15%,心肌梗死组4%,心肌炎组2%,正常CMR组2%(log-rank检验:19.9;p < 0.001)。
- 多变量Cox回归模型中,CMR诊断心肌病和就诊心电图ST段抬高是仅有的两个显著死亡预测因素。
- 以就诊心电图ST段抬高和CMR诊断心肌病为风险标志,具备0、1、2个因素者的死亡率分别为2%、11%、21%(p < 0.0001)。
临床应用与阅片要点
- 对MINOCA患者,CMR可在中位37天时明确约四分之三患者的病因,包括心肌炎、心肌梗死和心肌病。
- CMR诊断心肌病和就诊心电图ST段抬高与死亡风险升高相关;具备0、1、2个因素者死亡率分别为2%、11%、21%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study sought to assess the prognostic impact of cardiac magnetic resonance (CMR) and conventional risk factors in patients with myocardial infarction with nonobstructed coronaries (MINOCA).
BACKGROUND: Myocardial infarction with nonobstructed coronary arteries (MINOCA) represents a diagnostic dilemma, and the prognostic markers have not been clarified.
METHODS: A total of 388 consecutive patients with MINOCA undergoing CMR assessment were identified retrospectively from a registry database and prospectively followed for a primary clinical endpoint of all-cause mortality. A 1.5-T CMR was performed using a comprehensive protocol (cines, T2-weighted, and late gadolinium enhancement sequences). Patients were grouped into 4 categories based on their CMR findings: myocardial infarction (MI) (embolic/spontaneous recanalization), myocarditis, cardiomyopathy, and normal CMR.
RESULTS: CMR (performed at a median of 37 days from presentation) was able to identify the cause for the troponin rise in 74% of the patients (25% myocarditis, 25% MI, and 25% cardiomyopathy), whereas a normal CMR was identified in 26%. Over a median follow-up of 1,262 days (3.5 years), 5.7% patients died. The cardiomyopathy group had the worst prognosis (mortality 15%; log-rank test: 19.9; p < 0.001), MI had 4% mortality, and 2% in both myocarditis and normal CMR. In a multivariable Cox regression model (including clinical and CMR parameters), CMR diagnosis of cardiomyopathy and ST-segment elevation on presentation electrocardiogram (ECG) remained the only 2 significant predictors of mortality. Using presentation with ECG ST-segment elevation and CMR diagnosis of cardiomyopathy as risk markers, the mortality risk rates were 2%, 11%, and 21% for presence of 0, 1, and 2 factors, respectively (p < 0.0001).
CONCLUSIONS: In a large cohort of patients with MINOCA, CMR (median 37 days from presentation) identified a final diagnosis in 74% of patients. Cardiomyopathy had the highest mortality, followed by MI. The strongest predictors of mortality were a CMR diagnosis of cardiomyopathy and ST-segment elevation on presentation ECG.
引用
- Dastidar AG, Baritussio A, De Garate E, et al. Prognostic Role of CMR and Conventional Risk Factors in Myocardial Infarction With Nonobstructed Coronary Arteries. JACC Cardiovasc Imaging. 2019. PMID: 30772224. doi:10.1016/j.jcmg.2018.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。